Department of Biochemistry and Developmental Biology

Search results

• University of Helsinki: Researchers Identified Factors That Turn Normal Cells Into Liver Cancer Cells

  Sampsa Hautaniemi & Biswajyoti Sahu

  08/09/2021

  1 item of Media coverage

  Press/Media: Press / Media

• 388123-2021: Finland-Helsingin yliopisto: Services provided by medical laboratories

  Sampsa Hautaniemi

  30/07/2021

  1 item of Media coverage

  Press/Media: Press / Media

• Next Generation Sequencing Services for Decider

  Sampsa Hautaniemi

  09/03/2021

  1 item of Media coverage

  Press/Media: Press / Media

• Tender Notice: HELSINGIN YLIOPISTO Seeks "Next Generation Sequencing Services for Decider" (118211-2021)

  Sampsa Hautaniemi

  09/03/2021

  1 item of Media coverage

  Press/Media: Press / Media

• 118211-2021: Finland-Helsinki: Services provided by medical laboratories

  Sampsa Hautaniemi

  09/03/2021

  1 item of Media coverage

  Press/Media: Press / Media

• -KI researchers part of EU project to improve diagnostics and treatment of ovarian cancer with the help of AI

  Sampsa Hautaniemi

  08/02/2021

  1 item of Media coverage

  Press/Media: Press / Media

• European Union funds new project to improve personalized treatments for ovarian cancer

  Sampsa Hautaniemi

  05/02/2021

  1 item of Media coverage

  Press/Media: Press / Media

• University of Helsinki: DECIDER Project to Improve Diagnostics and Treatment of Ovarian Cancer With the Help of AI - 15 Million Euros in Funding From the EU

  Sampsa Hautaniemi

  05/02/2021

  1 item of Media coverage

  Press/Media: Press / Media

• Researchers to create computational models to improve treatments for ovarian cancer

  Sampsa Hautaniemi

  05/02/2021

  1 item of Media coverage

  Press/Media: Press / Media

• DECIDER project to improve diagnostics and treatment of ovarian cancer with the help of AI – 15 million euros in funding from the EU

  Sampsa Hautaniemi

  04/02/2021

  2 items of Media coverage

  Press/Media: Press / Media

• IRB Barcelona to participate in the DECIDER project, aimed at improving diagnostics and treatment of ovarian cancer

  Sampsa Hautaniemi

  04/02/2021

  1 item of Media coverage

  Press/Media: Press / Media

• IndiTreat® selected to prestigious multinational ovarian cancer project.

  Sampsa Hautaniemi

  04/02/2021

  3 items of Media coverage

  Press/Media: Press / Media

• A potential treatment for cardiac regeneration

  Maciej Lalowski & Esko Kankuri

  30/06/2020

  3 items of Media coverage

  Press/Media: Press / Media

• Researchers have found a promising therapy for cardiac regeneration

  Maciej Lalowski & Esko Kankuri

  30/06/2020

  5 items of Media coverage

  Press/Media: Press / Media

• Dana-Farber Cancer Institute: Scientists Identify Factors for Predicting Which Patients With Ovarian Cancer Won't Benefit From Immunotherapy-PARP Inhibitor Combination

  Sampsa Hautaniemi

  20/03/2020

  1 item of Media coverage

  Press/Media: Press / Media

• SCIENTISTS IDENTIFY FACTORS FOR PREDICTING WHICH PATIENTS WITH OVARIAN CANCER WON'T BENEFIT FROM IMMUNOTHERAPY-PARP INHIBITOR COMBINATION

  Sampsa Hautaniemi

  19/03/2020

  1 item of Media coverage

  Press/Media: Press / Media

• Dana-Farber Cancer Institute: Scientists identify factors for predicting which patients with ovarian cancer won't benefit from immunotherapy-PARP inhibitor combination

  Sampsa Hautaniemi

  19/03/2020

  1 item of Media coverage

  Press/Media: Press / Media

• New research shows which ovarian cancer patients won't benefit from immune-PARP combo

  Sampsa Hautaniemi

  19/03/2020

  1 item of Media coverage

  Press/Media: Press / Media

• Connecting energy metabolism to intestinal stem cell fate

  Tomi Mäkelä

  15/01/2020

  1 item of Media coverage

  Press/Media: Press / Media

• Director General Lea Kauppi selected as one of the top experts for the Horizon Europe

  Tomi Mäkelä

  31/07/2019

  1 item of Media coverage

  Press/Media: Press / Media

• Circulating tumor DNA gives treatment options for the most common ovarian cancer type

  Sampsa Hautaniemi

  06/05/2019 → 08/05/2019

  4 items of Media coverage

  Press/Media: Press / Media

• Taking 'molecular snapshots' of ovarian cancer

  Sampsa Hautaniemi

  07/05/2019

  1 item of Media coverage

  Press/Media: Press / Media

• Circulating tumour DNA gives treatment options for the most common ovarian cancer type

  Sampsa Hautaniemi

  07/05/2019

  1 item of Media coverage

  Press/Media: Press / Media

• Circulating tumor DNA can help detect treatment options for ovarian cancer subtype

  Sampsa Hautaniemi

  06/05/2019

  1 item of Media coverage

  Press/Media: Press / Media

• Circulating tumor DNA can help detect treatment options for ovarian cancer subtype

  Sampsa Hautaniemi

  06/05/2019

  1 item of Media coverage

  Press/Media: Press / Media